2013
DOI: 10.1074/mcp.m112.025569
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Identification of SUMOylation Sites in Human Proteins Using Affinity Enrichment and Paralog-specific Reporter Ions

Abstract: Protein modification by small ubiquitin-like modifier (SUMO) modulates the activities of numerous proteins involved in different cellular functions such as gene transcription, cell cycle, and DNA repair. Comprehensive identification of SUMOylated sites is a prerequisite to determine how SUMOylation regulates protein function. However, mapping SUMOylated Lys residues by mass spectrometry (MS) is challenging because of the dynamic nature of this modification, the existence of three functionally distinct human SU… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
31
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 44 publications
(35 citation statements)
references
References 36 publications
(22 reference statements)
3
31
1
Order By: Relevance
“…3). This script is different from that reported recently 30 and takes into account cleavages of residues within the SUMO3m remnant (for example, y 11 -NQ, y 11 -NQT and y 11 -NQTG in Fig. 2c).…”
Section: Tcl Mw Markercontrasting
confidence: 83%
See 1 more Smart Citation
“…3). This script is different from that reported recently 30 and takes into account cleavages of residues within the SUMO3m remnant (for example, y 11 -NQ, y 11 -NQT and y 11 -NQTG in Fig. 2c).…”
Section: Tcl Mw Markercontrasting
confidence: 83%
“…Capillary HPLC columns for nano-LC-MS were packed in-house using Jupiter C18 (3 mm) particles from Phenomenex (Torrance, CA) and fused silica tubing from Polymicro Technologies (Phoenix, AZ). All tryptic peptides with SUMO remnant chains were synthesized by automated SPOT synthesis as described previously 30 .…”
Section: Methodsmentioning
confidence: 99%
“…Of our 332 identified sites, 86 (26%) were previously reported in proteomic screens for SUMO sites (11,14,16,17,23,24), and 82 (25%) are reported in the PhosphoSitePlus database (a resource for human PTMs, including SUMOylation) (25), thereby validating our approach (Dataset S1). Thus, to our knowledge, 227 SUMO sites (203 for SUMO1 and 82 for SUMO2) were identified here for the first time (Dataset S1).…”
Section: Resultssupporting
confidence: 60%
“…Recent proteomic studies have also revealed Ub modification by a small Ub-like modifier (SUMO) at multiple Lys residues (Galisson et al, 2011;Lamoliatte et al, 2013;Hendriks et al, 2014). Additionally, ubiquitinated SUMO has also been reported (Lamoliatte et al, 2013;Hendriks et al, 2014).…”
Section: Different Forms Of Ubiquitin Modifications Exist In Naturementioning
confidence: 99%